维普期刊资源整合服务平台（V6.5）

57篇 您的检索式：作者名="PICCART MJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Systemic treatment for locally advanced breast cancer:what we still need to learn after a decade of muttimodatity clinical trials显示文摘	Piccart MJ Kerger J Tomiak E	1992	Eur J Cancer1992，28，23：	1
2	Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide m women with advanced epithelial ovarian cancer:three-year results显示文摘	Piccart MJ Bertelsen K James K	2000	J Natl Cancer Inst2000，92，9：	1
3	New therapies for ovarian cancer: cytotoxics and molecularly targeted agents显示文摘	Dinh P Harnett P Piccart Geb hart MJ	2008	Crit Rev oncol Hematol2008，67，2：	1
4	Optimal therapeutic strategies in ovarian epithelial cancer in 1997显示文摘	Piccart MJ Noga ret JM	1997	Rev Med Brus1997，18，：	1
5	Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: a randomized phase Ⅱ study of the European organization for research and treatment of Cancer Gynecology Group显示文摘	Piccart MJ Green JA Lacave AJ		J Glin Oncol0，，：	1
6	Current and future potential roles of the platinum drugs in the treatment of ovarian cancer显示文摘	Piccart MJ Lamb H Vermorken JB	2001	Ann Oncol2001，12，9：	1
7	Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of muhimodality clinical trials显示文摘	Piccart MJ Kerger J Tomiak E	1992	Eur J Cancer1992，28，23：	1
8	HER2 - positive breast cancer: from trastuzumab to innovatory anti - HER2 strategies 显示文摘	Whenham N D'Hondt V Piccart MJ	2008	Clin Breast Cancer2008，8，1：	1
9	Phase Ⅰ study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis显示文摘	Tomiak E Piccart MJ Kerger J	1994	J Clin Oncol1994，12，7：	1
10	Intraperitoneal cisplatin versus no further treatment:8-year results of EORTC 55875,a randomized phase Ⅲ study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy显示文摘	Piccart MJ Floquet A Scarfone G	2003	Int J Gynecol Cancer2003，13，2：	1
11	Adjuvant chemotherapy in 2005:standards and beyond显示文摘	Piccart MJ de Valeriola D Dal Lago L	2005	Breast2005，14，6：	1
12	Trastuzumab after adjuvant chemotherapy in HER-2-positive breast cancer显示文摘	Piccart Gebhart MJ Procter M Leyland Jones B	2005	N Engl J Med2005，353，16：	1
13	HER-2:a predictive factor ready to use in the daily management of breast cancer patients显示文摘	Piccart MJ Di Leo A Hamilton A	2000	Eur J Cancer2000，36，14：	1
14	Use and abuse of taxanes in the management of metastatic breast caneer显示文摘	BERNARD-MARTY C CARDOSO F PICCART MJ	2003	European Journal of Cancer2003，39，14：	1
15	Optimizing anthracycline therapy for node positive breast cancer显示文摘	Cardoso F Atalay G Piccart MJ	2002	Am J Cancer2002，1，：	1
16	Facts and controversies in systemic treatment of metastatic breast cancer显示文摘	Bernard-Marty C Cardoso F Piccart MJ	2004	Oncologist2004，9，：	1
17	Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovar-ian cancer显示文摘	Piccart MJ Bertelsen K Sturart G	2004	Int J Gynecol Cancer2004，14，4：	1
18	Systemic treatment for locally advanced breast cancer:what we still need to learn after a decade of multimodality clinical trials显示文摘	Piccart MJ Kerger J Tomiak E	1992	Eur J Cancer1992，28，23：	1
19	Intrapefitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase m study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy显示文摘	Piccart MJ Floquet A Scarfone G	2003	Int J Gynecol Cancer2003，132，：	1
20	Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis显示文摘	Tomiak E Piccart MJ Kerger J	1994	Journal of Clinical Oncology1994，12，7：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示